Steven Hu

Interleukin-1 and Tumor Necrosis Factor-α Synergistically Mediate Neurotoxicity: Involvement of Nitric Oxide and of N-Methyl-D-aspartate Receptors

C C Chao, Steven Hu, L. Ehrlich et al. · Brain Behavior and Immunity · 1995 · 413 citations

Life Sciences, Immunology, Neuroscience +14

Development of chitosan nanoparticles as drug delivery system for a prototype capsid inhibitor

Meiyan Xue, Steven Hu, Yifei Lü et al. · International Journal of Pharmaceutics · 2015 · 68 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

<i>In silico</i> and <i>in vitro</i> pharmacogenetic analysis in mice

Yingying Guo, Peng Lü, Erin Farrell et al. · Proceedings of the National Academy of Sciences · 2007 · 51 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine—a potent, orally active Src kinase inhibitor with anti-tumor activity in preclinical assays

Glenn Noronha, Kathy Barrett, Antonio Boccia et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration

Moorthy S. S. Palanki, Hideo Akiyama, Peter A. Campochiaro et al. · Journal of Medicinal Chemistry · 2008 · 45 citations · Full text

Medicine, Ophthalmology, Pharmacology +16